Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.21
0.13 (4.22%)
At close: Aug 20, 2025, 3:59 PM
3.25
1.24%
After-hours: Aug 20, 2025, 04:43 PM EDT

Cumberland Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-735.21K 1.25M -1.9M -1.54M -1.09M -1.95M -6.29M -1.06M 862.15K 172.29K -2.46M -423.23K -1.36M -1.4M -2.39M -2.58M 1.22M 144.66K
Depreciation & Amortization
1.32M 1.32M 1.78M 1.4M 1.42M 1.44M 1.23M 1.25M 1.2M 1.26M 511.48K 1.54M 1.62M 1.65M 1.08M 1.07M 1.23M 1.23M
Stock-Based Compensation
80.69K 74.21K 74.81K 76.37K 71.96K 78.75K 93.89K 83.11K 97.88K 90.16K 126.91K 188.45K -27.75K 159.9K 224.79K 162.17K 191.95K 162.96K
Other Working Capital
654.02K -453.06K -970.88K 1.07M -67.5K 148.52K -1.7M -222.18K -696.56K 152.09K -1.24M 2.34M -329.76K -131.35K -2.28M 563.26K 133.63K 207.16K
Other Non-Cash Items
-77.72K 131.52K -475.67K -1.93M 3.73M 4.18M 9.08M -771.65K 1.58M -2.14M -3.85M 1.23M -678.27K 594.86K -2.74M 722.78K -535.66K -837.9K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -5.27M n/a n/a n/a 48.15K 6.9K 6.9K n/a 503.32K 496.79K -1.69M 495.41K
Change in Working Capital
256.94K 1.13M 2.43M 2.46M -1.07M -1.39M 2.19M 1.74M 1.5M -795.12K 8.47M 886.62K 2.78M -1.16M 5.29M 20.28K 2.28M 592.81K
Operating Cash Flow
843.8K 3.9M 1.9M 475.5K -855.66K -2.14M 1.04M 1.24M 5.24M -1.42M 2.84M 3.43M 2.33M -150.5K 1.96M -102.01K 2.7M 1.79M
Capital Expenditures
-26.49K -47.63K -26.81K 40.81K -46.8K -58.19K -86.72K -95.07K -96.81K -174.45K -846.72K -1.01M -172.59K -41.9K -79.36K -108.24K -48.51K -118.34K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 13.5M n/a n/a -13.5M n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -200K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
312.35K -1.18M -24.53K 148.83K -39.63K -16.57K 347.36K -41.93K -24.61K -67.19K -12.5M 899.35K -35.34K -14.91K 52.57K -48.29K -33.44K -298.88K
Investing Cash Flow
285.86K -1.23M -26.81K 189.64K -46.8K -58.19K 260.64K -95.07K -96.81K -174.45K 153.28K -113.25K -172.59K -13.54M -26.8K -108.24K -48.51K -318.34K
Debt Repayment
n/a -10.04M -815.42K n/a 7.45K 3.3M -138.98K -225K -2.92M -127.71K -1.5M -1.3M -1M 5M n/a 1M -1M n/a
Common Stock Repurchased
-7.17K -245.87K -98.38K -98.81K -134.25K -247.6K -188.97K -201.65K -162.79K -187.12K -189.66K -75.09K -208.16K -580.13K -361.19K -247.99K -474.86K -302.8K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-143.63K 4.76M -464.57K -438.02K -182.78K -630.7K -1.16M -455.94K -188.68K -1.46M -1.09M -616.07K n/a -501.5K -374.11K -368.99K -428.31K -995.28K
Financial Cash Flow
-150.8K -5.53M -1.38M -536.84K -309.57K 2.42M -1.49M -882.6K -3.28M -1.78M -2.78M -1.99M -1.21M 3.92M -735.3K 383.02K -1.9M -1.3M
Net Cash Flow
978.87K -2.86M 499.43K 128.31K -1.21M 226.86K -186.34K 258.88K 1.86M -3.37M 216.43K 1.32M 949.78K -9.77M 1.2M 172.77K 747.54K 169.13K
Free Cash Flow
817.32K 3.85M 1.88M 516.32K -902.46K -2.19M 953.4K 1.14M 5.14M -1.59M 2M 2.42M 2.16M -192.4K 1.88M -210.25K 2.65M 1.67M